Inhibition of Proteinase K Activity by Copper(II) Ions,
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Disease-related prion protein, PrPSc, can be distinguished from its normal cellular precursor, PrPC, by its detergent insolubility and partial resistance to proteolysis. Several studies have suggested that copper(II) ions can convert PrPC to a proteinase K-resistant conformation; however, interpretation of these studies is complicated by potential inhibition of proteinase K (PK) by copper(II) ions. Here we have examined directly the kinetic and equilibrium effects of copper(II) ions on PK activity using a simple synthetic substrate, p-nitrophenyl acetate. We show that at equilibrium two to three copper(II) ions bind stoichiometrically to PK and destroy its activity (Kd < 1 microM). This inhibition has two components, an initial reversible and weak binding phase and a slower, irreversible abolition of activity with a half-time of 6 min at saturating copper(II) ion concentrations. Copper(II) ions produce a similar biphasic inhibition of PK activity in the presence of brain homogenate but only when the copper(II) ion concentration exceeds that of the chelating components present in brain tissue. Under these conditions, the apparent resistance of PrPC to proteolysis by PK appears to be directly attributable to the inhibition of PK activity by copper(II) ions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Creatine has been shown to increase the sprint capacity when performing repeated sprints [83].”
From Periodized Nutrition for Athletes (2017) · cites this paper as [83]
Citations
Cites
Prion Diseases of Humans and Animals: Their Causes and Molecular Basis
Collinge, J. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.519 · Cited by 1,344
Self-citationNature of the Scrapie Agent: Self-replication and Scrapie
GRIFFITH, J. S. (1967) · Nature · doi:10.1038/2151043a0 · Cited by 1,161 · cited 1×
“According to the protein-only hypothesis ( 4 ), an abnormal PrP isoform is the principal, if not sole, component of the transmissible prion, with prion propagation occurring through PrPSc acting to replicate itself with high fidelity by recruiting endogenous PrPC (1, 2). The formation of PrPSc from PrPC is associated…”
BackgroundMouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins
Kascsak, R. J., Rubenstein, R., Merz, P. A., Tonna-DeMasi, M., Fersko, R., Carp, R. I., Wisniewski, H. M., & Diringer, H. (1987) · Journal of Virology · doi:10.1128/jvi.61.12.3688-3693.1987 · Cited by 766
Wadsworth, J., Joiner, S., Hill, A., Campbell, T., Desbruslais, M., Luthert, P., & Collinge, J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05403-4 · Cited by 693
Self-citationConsequences of manganese replacement of copper for prion protein function and proteinase resistance
Brown, D. R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.6.1180 · Cited by 269 · cited 1×
“Central to the work described here, the role of copper(II) ions in the conversion of PrP C to PrPSc and in the pathogenesis of prion diseases has generated much interest (5-12).”
BackgroundCopper(II) Inhibits in Vitro Conversion of Prion Protein into Amyloid Fibrils
Bocharova, O. V., Breydo, L., Salnikov, V. V., & Baskakov, I. V. (2005) · Biochemistry · doi:10.1021/bi050251q · Cited by 171
Molecular and clinical classification of human prion disease
Wadsworth, J. D. F., Hill, A. F., Beck, J. A., & Collinge, J. (2003) · British Medical Bulletin · doi:10.1093/bmb/66.1.241 · Cited by 155
Self-citationCopper(II)-induced Conformational Changes and Protease Resistance in Recombinant and Cellular PrP
Qin, K., Yang, D.-S., Yang, Y., Chishti, M. A., Meng, L.-J., Kretzschmar, H. A., Yip, C. M., Fraser, P. E., & Westaway, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.25.19121 · Cited by 153 · cited 1×
“Central to the work described here, the role of copper(II) ions in the conversion of PrP C to PrPSc and in the pathogenesis of prion diseases has generated much interest (5-12).”
BackgroundReversibility of Scrapie Inactivation Is Enhanced by Copper
McKenzie, D., Bartz, J., Mirwald, J., Olander, D., Marsh, R., & Aiken, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25545 · Cited by 134
Kim, N.-H., Choi, J.-K., Jeong, B.-H., Kim, J.-I., Kwon, M.-S., Carp, R. I., & Kim, Y.-S. (2005) · The FASEB Journal · doi:10.1096/fj.04-2117fje · Cited by 61 · cited 1×
“Central to the work described here, the role of copper(II) ions in the conversion of PrP C to PrPSc and in the pathogenesis of prion diseases has generated much interest (5-12).”
Background
Research works printed but not linked: 18
- Prusiner S. B., 1998, Proc. Natl. Acad. Sci. U.S.A. 95
- Collinge J., Annu. Rev. Neurosci. 24, 519−550.
- Wadsworth J. D., 2003, Bull. 66, 241−254.
- Griffith J. S., 1967, Nature 215, 1043−1044.
- McKenzie D., 1998, J. Biol. Chem. 273, 25545−25547.
- Qin K., 1912, Effect of protein age and deamidation, J. Biol. Chem. 275, 1, 19131
- Brown D. R., 2000, EMBO J. 19, 1180−1186.
- Wong B. S., 2000, Biochem. Biophys. Res. Commun. 276, 1217−1224.
- Kuczius T., 2004, Biol. Chem. 385, 739−747.
- Nishina K., 2004, J. Biol. Chem. 279, 40788−40794.
- Kim N. H., 2005, Cu, Fe) and deoxycholic acid (DA) on the conversion of PrPC to PrPres, FASEB J. 19, 783−785.
- Bocharova O. V., 2005, Biochemistry 44, 6776−6787.
- Muller A., 1993, J. Biol. Chem. 268, 26150−26154.
- Saxena A. K., 1996, Proteins 25, 195−201.
- Kascsak R. J., 1987, J. Virol. 61, 3688−3693.
- Wadsworth J. D. F., 2001, Lancet 358, 171−180.
- Müller A., 1994, J. Biol. Chem. 269, 23108−23111.
- Abbreviations NA, p-nitrophenyl acetate
Cited by
Kreider, R. B., Kalman, D. S., Antonio, J., Ziegenfuss, T. N., Wildman, R., Collins, R., Candow, D. G., Kleiner, S. M., Almada, A. L., & Lopez, H. L. (2017) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-017-0173-z · Cited by 1,057
The creatine kinase system and pleiotropic effects of creatine
Wallimann, T., Tokarska-Schlattner, M., & Schlattner, U. (2011) · Amino Acids · doi:10.1007/s00726-011-0877-3 · Cited by 797
Creatine supplementation with specific view to exercise/sports performance: An update
Cooper, R., Naclerio, F., Allgrove, J., & Jimenez, A. (2012) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-9-33 · Cited by 306
Periodized Nutrition for Athletes
Jeukendrup, A. E. (2017) · Sports Medicine · doi:10.1007/s40279-017-0694-2 · Cited by 299
In sickness and in health: the widespread application of creatine supplementation
Gualano, B., Roschel, H., Lancha, A. H., Brightbill, C. E., & Rawson, E. S. (2012) · Amino Acids · doi:10.1007/s00726-011-1132-7 · Cited by 172
Metadata
- Authors
- Stone, L. A., Jackson, G. S., Collinge, J., Wadsworth, J. D. F., & Clarke, A. R.
- Affiliations
- MRC Prion Unit (GB)
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2006-12-13
- Volume
- 46
- Issue
- 1
- Pages
- 245-252
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W1987403976
- Cited by
- 43
- References
- 16
- Citations by year
- 2025: 1 · 2023: 1 · 2022: 3 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 3 · 2017: 4 · 2016: 4 · 2015: 2 · 2012: 4
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Explore Bristol Research (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- proteinase K, copper(II) ions, enzyme inhibition, prion protein, PrPSc, cellular prion protein, protease resistance, p-nitrophenyl acetate, copper binding, irreversible inhibition, brain homogenate, prion conversion
- MeSH terms
- Animals, Brain, Copper, Dose-Response Relationship, Drug, Cricetinae, Hydrogen-Ion Concentration, Kinetics, Time Factors, PrPSc Proteins, PrPC Proteins, Endopeptidase K
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of Proteinase K Activity by Copper(II) Ions,. https://app.cochat.ai/papers/10.1021/bi061646s
- The paper
- Stone, L. A., Jackson, G. S., Collinge, J., Wadsworth, J. D. F., & Clarke, A. R. (2007). Inhibition of Proteinase K Activity by Copper(II) Ions,. Biochemistry. https://doi.org/10.1021/bi061646s
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.